Posted on: 02 September, 2021
The largest study of its type in Australia will investigate the impact of COVID-19 on younger patients with new trends emerging around the cardiac complications from the Delta strain of the virus.
Launched last year, the AUS-COVID trial assessed more than 640 patients in 21 hospitals across Australia, recording cardiovascular complications.
From this group, 125 were people were admitted to intensiv.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 22 June, 2021
Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock has been recognised for her extraordinary contribution to healthcare in this year’s Queen’s birthday honour roll.
Professor Pollock has been appointed an officer of the order of Australia for her distinguished service to medical research, education and science, nephrology, and clinical practice and governa.....
Read more
Category: Awards, Cardiovascular and Renal Research, Research Excellence
Posted on: 31 May, 2021
Two leading cardiovascular experts have been appointed to a prestigious world expert panel to reduce rates of cardiovascular disease in women.
Royal North Shore Hospital (RNSH) interventional cardiologist and Kolling Institute researcher, Professor Gemma Figtree, and RNSH senior hospital scientist and Kolling Institute researcher, Dr Anastasia Mihailidou, have been appointed commissioners of The La.....
Read more
Category: Cardiovascular and Renal Research
Posted on: 26 April, 2021
A team of researchers from the Kolling Institute, The University of Sydney, Monash University and La Trobe University have led a global call to action to accelerate new approaches for cardiovascular disease (CVD) drug solutions.
CVD is the leading cause of death globally. Since the start of the pandemic approximately 18 million people have died of CVD, with the majority from low- and middle-income .....
Read more
Category: Cardiovascular and Renal Research
Posted on: 14 April, 2021
Two of our leading researchers will drive key Australian projects following a funding announcement from the National Health and Medical Research Council. (NHMRC)
More than $1.4 million from the partnership grant program will go to Kolling researcher and RNSH interventional cardiologist Professor Gemma Figtree and her team for a study to reduce coronary artery disease. The world-first project will r.....
Read more
Category: Cardiovascular and Renal Research
Posted on: 14 December, 2020
Kolling researcher and Royal North Shore Hospital cardiologist Dr Rebecca Kozor will lead a world-first study using MRI technology to improve the diagnosis of heart failure.
The trial has been made possible following a $50,000 Cardiac Society of Australia and New Zealand-Boehringer Ingelheim innovation grant.
Dr Kozor has welcomed the funding to quantify pulmonary congestion or lung water density i.....
Read more
Category: Cardiovascular and Renal Research, Funding support
Posted on: 14 December, 2020
The Kolling’s Women and Babies Research team is calling for a reduction in the number of early births, with the latest research highlighting the benefits of labour as close to 40 weeks as possible.
Twenty years ago, the majority of women gave birth at 40 weeks. Today it’s between 38 and 39 weeks and continuing to get earlier.
This trend is due to the growing number of planned early births at 36, 37.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 04 November, 2020
Professor Gemma Figtree has led a successful bid for a Cardiovascular Centre of Excellence, securing $2.5 million in funding from the National Health and Medical Research Council. (NHMRC)
Around 20 national and international collaborators will be involved in the research, targeting the global heart disease epidemic through new diagnostic techniques and prevention strategies.
Professor Figtree has w.....
Read more
Category: Cardiovascular and Renal Research, Funding support